Target intelligence / Profile preview

Ubiquitin specific peptidase 17 like family member 3 (USP17L3)

Target
USP17L3
Molecular classification
Enzyme, Deubiquitinating enzyme, Cysteine-type peptidase
01

Overview

Ubiquitin specific peptidase 17 like family member 3 (USP17L3) is a cysteine-type deubiquitinating enzyme that removes conjugated ubiquitin from substrate proteins to regulate diverse cell processes, including protein stability, cell proliferation, apoptosis, cell cycle progression, cell migration, and response to cytokines and chemokines. Induction of USP17L3 has been observed in response to inflammatory and migratory cues (e.g., chemokines like CXCL12 and IL-8) in immune and cancer cells, where it is required for both directional and random migration by regulating cytoskeletal rearrangements and the localization of small GTPases such as Ras, RhoA, Rac1, and Cdc42. It has been identified as a regulator downstream of cytokine and chemokine signaling and is implicated in processes relevant to inflammation and metastatic cancer[1][3][8]. Genetic associations with developmental disorders have also been reported[3].

Other names
Ubiquitin carboxyl-terminal hydrolase 17-like protein 3USP17BUSP17FDeubiquitinating enzyme 17-like protein 3Ubiquitin thioesterase 17-like protein 3Ubiquitin-specific-processing protease 17-like protein 3ubiquitin specific peptidase 17-like 3ubiquitin thioesterase 17-like protein 3USP17L3
02

Mechanism of action

Removal of conjugated ubiquitin from substrate proteins to regulate their stability and function, affecting cell cycle, migration, and signaling pathways[3][8][1].

03

Biological functions

Regulation of protein stabilityDeubiquitinationCell proliferationCell cycle progressionApoptosisCell migrationCellular response to viral infection
04

Disease associations

Cancer (implicated in migration and metastasis)InflammationDevelopmental and epileptic encephalopathies (genetic association)Partington syndrome (genetic association)
05

Safety considerations

Possible roles in cancer progression and immune regulation suggest potential for toxicity or off-target effects in therapeutic targeting, but no direct drug safety data is available[1]

Beyond the preview

Go deeper on Ubiquitin specific peptidase 17 like family member 3 (USP17L3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin specific peptidase 17 like family member 3 (USP17L3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call